Glancy, Prongay & Murray LLP Commences Investigation on Behalf of Arena Pharmaceuticals, Inc. Investors
October 16 2015 - 5:54PM
Business Wire
Glancy, Prongay & Murray LLP (“GPM”) announces that it is
investigating potential claims on behalf of investors of Arena
Pharmaceuticals, Inc. (NASDAQ: ARNA) (“Arena” or “the Company”) and
whether the officers and directors complied with their legal
obligations to the Company and its shareholders.
Arena announced on October 5, 2015, that, “at the request of the
Board of Directors, Jack Lief, Arena's President and Chief
Executive Officer, has retired from the company, including its
Board of Directors.” The Company further disclosed that, “it is
conducting an ongoing evaluation of its programs and operations,
and intends to provide details regarding its 2016 financial plan
later this year.” GPM’s investigation focuses on whether the
Company and its directors have breached any fiduciary duties owed
to shareholders, or otherwise committed corporate waste and/or
permitted a lack of adequate internal controls with respect to the
announcement on October 5, 2015.
If you own Arena shares, if you have information or would like
to learn more about these claims, or have any questions concerning
this announcement or your rights or interests with respect to these
matters, please contact Lesley Portnoy, of GPM, 1925 Century Park
East, Suite 2100, Los Angeles, California 90067 at 310-201-9150,
Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com,
or visit our website at http://www.glancylaw.com. If you inquire by
email please include your mailing address, telephone number and
number of shares purchased.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151016006064/en/
Glancy, Prongay & Murray LLP, Los AngelesLesley Portnoy,
310-201-9150 or
888-773-9224shareholders@glancylaw.comwww.glancylaw.com
Arena Pharmaceuticals (NASDAQ:ARNA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Arena Pharmaceuticals (NASDAQ:ARNA)
Historical Stock Chart
From Apr 2023 to Apr 2024